SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $43,294 | -43.8% | 48,865 | -0.1% | 0.00% | – |
| Q3 2022 | $77,000 | -22.2% | 48,928 | -0.3% | 0.00% | -100.0% |
| Q2 2022 | $99,000 | -16.1% | 49,082 | -3.0% | 0.00% | 0.0% |
| Q1 2022 | $118,000 | -50.0% | 50,574 | -0.3% | 0.00% | 0.0% |
| Q4 2021 | $236,000 | -26.5% | 50,724 | +20.6% | 0.00% | -50.0% |
| Q3 2021 | $321,000 | -21.3% | 42,068 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $408,000 | +19.6% | 42,068 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $341,000 | +71.4% | 41,251 | +41.7% | 0.00% | +100.0% |
| Q4 2020 | $199,000 | +0.5% | 29,113 | +63.6% | 0.00% | 0.0% |
| Q3 2020 | $198,000 | +76.8% | 17,800 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $112,000 | +489.5% | 17,800 | +98.5% | 0.00% | – |
| Q3 2019 | $19,000 | -20.8% | 8,966 | 0.0% | 0.00% | – |
| Q2 2019 | $24,000 | -4.0% | 8,966 | +71.3% | 0.00% | – |
| Q1 2019 | $25,000 | +92.3% | 5,235 | 0.0% | 0.00% | – |
| Q4 2018 | $13,000 | – | 5,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |